Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Characterization of OP9 as authentic mesenchymal stem cell line.

Gao J, Yan XL, Li R, Liu Y, He W, Sun S, Zhang Y, Liu B, Xiong J, Mao N.

J Genet Genomics. 2010 Jul;37(7):475-82. doi: 10.1016/S1673-8527(09)60067-9.

PMID:
20659712
2.

Neurofibromatosis type 1 and high-grade tumors of the central nervous system.

Rosenfeld A, Listernick R, Charrow J, Goldman S.

Childs Nerv Syst. 2010 May;26(5):663-7. doi: 10.1007/s00381-009-1024-2. Epub 2009 Nov 25.

PMID:
19937438
3.

Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow.

Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T, Shimmura S, Miyawaki A, Nakagawa T, Suda T, Okano H, Matsuzaki Y.

J Exp Med. 2009 Oct 26;206(11):2483-96. doi: 10.1084/jem.20091046. Epub 2009 Oct 19.

4.

Neurofibromatosis type 1.

Boyd KP, Korf BR, Theos A.

J Am Acad Dermatol. 2009 Jul;61(1):1-14; quiz 15-6. doi: 10.1016/j.jaad.2008.12.051. Review.

5.

Endochondral ossification is required for haematopoietic stem-cell niche formation.

Chan CK, Chen CC, Luppen CA, Kim JB, DeBoer AT, Wei K, Helms JA, Kuo CJ, Kraft DL, Weissman IL.

Nature. 2009 Jan 22;457(7228):490-4. doi: 10.1038/nature07547. Epub 2008 Dec 10.

6.

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.

Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, Zhang S, Yang Y, Vakili ST, Yu M, Burns D, Robertson K, Hutchins G, Parada LF, Clapp DW.

Cell. 2008 Oct 31;135(3):437-48. doi: 10.1016/j.cell.2008.08.041.

7.

Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation.

Mirsky R, Woodhoo A, Parkinson DB, Arthur-Farraj P, Bhaskaran A, Jessen KR.

J Peripher Nerv Syst. 2008 Jun;13(2):122-35. doi: 10.1111/j.1529-8027.2008.00168.x. Review.

PMID:
18601657
8.

Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad.

Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, Satoh E, Morikawa S, Okada Y, Mabuchi Y, Katoh H, Okada S, Fukuda K, Suda T, Matsuzaki Y, Toyama Y, Okano H.

Cell Stem Cell. 2008 Apr 10;2(4):392-403. doi: 10.1016/j.stem.2008.03.005.

9.

The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

Joseph NM, Mosher JT, Buchstaller J, Snider P, McKeever PE, Lim M, Conway SJ, Parada LF, Zhu Y, Morrison SJ.

Cancer Cell. 2008 Feb;13(2):129-40. doi: 10.1016/j.ccr.2008.01.003.

10.

Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.

Zheng H, Chang L, Patel N, Yang J, Lowe L, Burns DK, Zhu Y.

Cancer Cell. 2008 Feb;13(2):117-28. doi: 10.1016/j.ccr.2008.01.002.

11.

Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.

Wu J, Williams JP, Rizvi TA, Kordich JJ, Witte D, Meijer D, Stemmer-Rachamimov AO, Cancelas JA, Ratner N.

Cancer Cell. 2008 Feb;13(2):105-16. doi: 10.1016/j.ccr.2007.12.027.

12.

Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.

Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, De Schepper S, De Paepe A, Mortier G, Janssens S, Speleman F, Legius E, Messiaen L.

Hum Mutat. 2006 Oct;27(10):1030-40.

PMID:
16941471
13.

Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system.

Nakamura T, Colbert MC, Robbins J.

Circ Res. 2006 Jun 23;98(12):1547-54. Epub 2006 May 18.

14.

The origin and development of glial cells in peripheral nerves.

Jessen KR, Mirsky R.

Nat Rev Neurosci. 2005 Sep;6(9):671-82. Review.

PMID:
16136171
15.

Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling.

Kl├ęber M, Lee HY, Wurdak H, Buchstaller J, Riccomagno MM, Ittner LM, Suter U, Epstein DJ, Sommer L.

J Cell Biol. 2005 Apr 25;169(2):309-20. Epub 2005 Apr 18.

16.

Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, Decourten-Myers G, Vogel KS, DeClue JE, Ratner N.

Cancer Cell. 2005 Jan;7(1):65-75.

17.

Comparative pathology of nerve sheath tumors in mouse models and humans.

Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, Messerli SM, McClatchey AI, Niwa-Kawakita M, Ratner N, Reilly KM, Zhu Y, Giovannini M.

Cancer Res. 2004 May 15;64(10):3718-24.

18.

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.

Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM.

Blood. 2004 Jun 1;103(11):4243-50. Epub 2004 Feb 24.

19.

Expression of soma-restricted proteolipid/DM20 proteins in lymphoid cells.

Feng JM, Fernandes AO, Bongarzone ER, Campagnoni CW, Kampf K, Campagnoni AT.

J Neuroimmunol. 2003 Nov;144(1-2):9-15.

PMID:
14597093
20.

Supplemental Content

Support Center